351. Guerin, E.; Cambray, G.; Sanchez-Alberola, N.; Campoy, S.; Erill, I.; Da Re, S.; Gonzalez-Zorn, B.; Barbe, J.; Ploy, M.C.; Mazel, D. The SOS response controls integron recombination. *Science* **2009**, *324*, 1034.

352. Hoffman, L.R.; D'Argenio, D.A.; MacCoss, M.J.; Zhang, Z.; Jones, R.A.; Miller, S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. *Nature* **2005**, *436*, 1171–1175.

353. Kohanski, M.A.; DePristo, M.A.; Collins, J.J. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. *Mol. Cell* **2010**, *37*, 311–320.

354. Peters, B.M.; Jabra-Rizk, M.A.; O'May, G.A.; Costerton, J.W.; Shirtliff, M.E. Polymicrobial interactions: impact on pathogenesis and human disease. *Clin. Microbiol. Rev.* **2012**, *25*, 193–213.

355. Wolcott, R.; Costerton, J.W.; Raoult, D.; Cutler, S.J. The polymicrobial nature of biofilm infection. *Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis.* **2013**, *19*, 107–112.

356. Frank, D.N.; Wilson, S.S.; St Amand, A.L.; Pace, N.R. Culture-independent microbiological analysis of foley urinary catheter biofilms. *PLoS One* **2009**, *4*, e7811.

357. Larsen, M.K.; Thomsen, T.R.; Moser, C.; Hoiby, N.; Nielsen, P.H. Use of cultivation-dependent and -independent techniques to assess contamination of central venous catheters: a pilot study. *BMC Clin. Pathol.* **2008**, *8*, 10.

358. Donelli, G.; Vuotto, C.; Cardines, R.; Mastrantonio, P. Biofilm-growing intestinal anaerobic bacteria. *FEMS Immunol. Med. Microbiol. 2012*, **65**, 318–325.

359. Ramsey, M.M.; Rumbaugh, K.P.; Whiteley, M. Metabolite cross-feeding enhances virulence in a model polymicrobial infection. *PLoS Pathog.* **2011**, *7*, e1002012.

360. Korgaonkar, A.; Trivedi, U.; Rumbaugh, K.P.; Whiteley, M. Community surveillance enhances *Pseudomonas aeruginosa* virulence during polymicrobial infection. *Proc. Natl. Acad. Sci. USA* **2013**, *110*, 1059–1064.

361. Armbruster, C.E.; Hong, W.; Pang, B.; Weimer, K.E.; Juneau, R.A.; Turner, J.; Swords, W.E. Indirect pathogenicity of *Haemophilus influenzae* and *Moraxella catarrhalis* in polymicrobial otitis media occurs via interspecies quorum signaling. *MBio* **2010**, *1*, e00102.

362. Dalton, T.; Dowd, S.E.; Wolcott, R.D.; Sun, Y.; Watters, C.; Griswold, J.A.; Rumbaugh, K.P. An *in vivo* polymicrobial biofilm wound infection model to study interspecies interactions. *PLoS One* **2011**, *6*, e27317.

363. Kline, K.A.; Schwartz, D.J.; Gilbert, N.M.; Hultgren, S.J.; Lewis, A.L. Immune modulation by group B *Streptococcus* influences host susceptibility to urinary tract infection by uropathogenic *Escherichia coli*. *Infect. Immun.* **2012**, *80*, 4186–4194.

364. Conrad, D.; Haynes, M.; Salamon, P.; Rainey, P.B.; Youle, M.; Rohwer, F. Cystic fibrosis therapy: a community ecology perspective. *Am. J. Respir. Cell Mol. Biol. 2013*, **48**, 150–156.

365. Costello, E.K.; Stagaman, K.; Dethlefsen, L.; Bohannan, B.J.; Relman, D.A. The application of ecological theory toward an understanding of the human microbiome. *Science* **2012**, *336*, 1255–1262.

366. Reppas, A.I.; Spiliotis, K.G.; Siettos, C.I. Epidemionics: from the host-host interactions to the systematic analysis of the emergent macroscopic dynamics of epidemic networks. *Virulence* **2010**, *1*, 338–349.
367. Zur Wiesch, P.A.; Kouyos, R.; Engelstadter, J.; Regoes, R.R.; Bonhoeffer, S. Population biological principles of drug-resistance evolution in infectious diseases. *Lancet Infect. Dis.* **2011**, *11*, 236–247.

368. Kim, H.U.; Sohn, S.B.; Lee, S.Y. Metabolic network modeling and simulation for drug targeting and discovery. *Biotechnol. J.* **2012**, *7*, 330–342.

369. Chavali, A.K.; D'Auria, K.M.; Hewlett, E.L.; Pearson, R.D.; Papin, J.A. A metabolic network approach for the identification and prioritization of antimicrobial drug targets. *Trends Microbiol.* **2012**, *20*, 113–123.

370. Sigurdsson, G.; Fleming, R.M.; Heinken, A.; Thiele, I. A systems biology approach to drug targets in *Pseudomonas aeruginosa* biofilm. *PLoS One* **2012**, *7*, e34337.

371. Fagerlind, M.G.; Webb, J.S.; Barraud, N.; McDougald, D.; Jansson, A.; Nilsson, P.; Harlen, M.; Kjelleberg, S.; Rice, S.A. Dynamic modelling of cell death during biofilm development. *J. Theor. Biol.* **2012**, *295*, 23–36.

372. Ilie, O.; van Loosdrecht, M.C.; Picioreanu, C. Mathematical modelling of tooth demineralisation and pH profiles in dental plaque. *J. Theor. Biol.* **2012**, *309*, 159–175.

373. Hindre, T.; Knibbe, C.; Beslon, G.; Schneider, D. New insights into bacterial adaptation through *in vivo* and *in silico* experimental evolution. *Nat. Rev. Microbiol.* **2012**, *10*, 352–365.

374. Kawecki, T.J.; Lenski, R.E.; Ebert, D.; Hollis, B.; Olivieri, I.; Whitlock, M.C. Experimental evolution. *Trends Ecol. Evol.* **2012**, *27*, 547–560.

375. Bianconi, I.; Milani, A.; Cigana, C.; Paroni, M.; Levesque, R.C.; Bertoni, G.; Bragonzi, A. Positive signature-tagged mutagenesis in *Pseudomonas aeruginosa*: tracking patho-adaptive mutations promoting airways chronic infection. *PLoS Pathog.* **2011**, *7*, e1001270.

376. Hogardt, M.; Heesemann, J. Microevolution of *Pseudomonas aeruginosa* to a Chronic Pathogen of the Cystic Fibrosis Lung. *Curr Top. Microbiol. Immunol.* **2012**, *358*, 91-118.

377. Traverse, C.C.; Mayo-Smith, L.M.; Poltak, S.R.; Cooper, V.S. Tangled bank of experimentally evolved *Burkholderia* biofilms reflects selection during chronic infections. *Proc. Natl. Acad. Sci. USA* **2012**, *110*, E250-259.

378. Yang, L.; Jelsbak, L.; Marvig, R.L.; Damkiaer, S.; Workman, C.T.; Rau, M.H.; Hansen, S.K.; Folkesson, A.; Johansen, H.K.; Ciofu, O.; et al. Evolutionary dynamics of bacteria in a human host environment. *Proc. Natl. Acad. Sci. USA* **2011**, *108*, 7481–7486.

379. Holmes, E.; Kinross, J.; Gibson, G.R.; Burcelin, R.; Jia, W.; Pettersson, S.; Nicholson, J.K. Therapeutic modulation of microbiota-host metabolic interactions. *Sci. Transl. Med.* **2012**, *4*, 137rv136.

380. Mee, M.T.; Wang, H.H. Engineering ecosystems and synthetic ecologies. *Mol. bioSystems* **2012**, *8*, 2470–2483.

381. Anderl, J.N.; Franklin, M.J.; Stewart, P.S. Role of antibiotic penetration limitation in *Klebsiella pneumoniae* biofilm resistance to ampicillin and ciprofloxacin. *Antimicrob. Agents Chemother.* **2000**, *44*, 1818–1824.

382. Zuroff, T.R.; Bernstein, H.; Lloyd-Randolfi, J.; Jimenez-Taracido, L.; Stewart, P.S.; Carlson, R.P. Robustness analysis of culturing perturbations on *Escherichia coli* colony biofilm beta-lactam and aminoglycoside antibiotic tolerance. *BMC Microbiol.* **2010**, *10*, 185.
383. Genevaux, P.; Muller, S.; Bauda, P. A rapid screening procedure to identify mini-Tn10 insertion mutants of *Escherichia coli* K-12 with altered adhesion properties. *FEMS Microbiol. Lett.* **1996**, *142*, 27–30.

384. Chavant, P.; Gaillard-Martinie, B.; Talon, R.; Hébraud, M.; Bernardi, T. A new device for rapid evaluation of biofilm formation potential by bacteria. *J. Microbiol. Methods* **2007**, *68*, 605–612.

385. Ceri, H.; Olson, M.E.; Stremick, C.; Read, R.R.; Morck, D.; Buret, A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. *J. Clin. Microbiol.* **1999**, *37*, 1771–1776.

386. Merritt, J.H.; Kadouri, D.E.; O'Toole, G.A. Growing and analyzing static biofilms. In *Current Protocols in Microbiology*; John Wiley & Sons: , 2005; Vol. 1B1, pp. 1-17.

387. Heydorn, A.; Nielsen, A.T.; Hentzer, M.; Sternberg, C.; Givskov, M.; Ersbøll, B.K.; Molin, S. Quantification of biofilm structures by the novel computer program COMSTAT. *Microbiology* (*Reading, Engl*) **2000**, *146*, 2395–2407.

388. Donlan, R.M.; Piede, J.A.; Heyes, C.D.; Sanii, L.; Murga, R.; Edmonds, P.; El-Sayed, I.; El-Sayed, M.A. Model system for growing and quantifying *Streptococcus pneumoniae* biofilms *in situ* and in real time. *Appl. Environ. Microbiol.* **2004**, *70*, 4980–4988.

389. Ghigo, J.M. Natural conjugative plasmids induce bacterial biofilm development. *Nature* **2001**, *412*, 442–445.

390. McCoy, W.F.; Bryers, J.D.; Robbins, J.; Costerton, J.W. Observations of fouling biofilm formation. *Can. J. Microbiol.* **1981**, *27*, 910–917.

391. Woods, J.; Boegli, L.; Kirker, K.R.; Agostinho, A.M.; Durch, A.M.; Delancey Pulcini, E.; Stewart, P.S.; James, G.A. Development and application of a polymicrobial, *in vitro*, wound biofilm model. *J. Appl. Microbiol.* **2012**, *112*, 998–1006.

392. Xu, K.D.; Stewart, P.S.; Xia, F.; Huang, C.T.; McFeters, G.A. Spatial physiological heterogeneity in *Pseudomonas aeruginosa* biofilm is determined by oxygen availability. *Appl. Environ. Microbiol.* **1998**, *64*, 4035–4039.

393. Richter, L.; Stepper, C.; Mak, A.; Reinthaler, A.; Heer, R.; Kast, M.; Bruckl, H.; Ertl, P. Development of a microfluidic biochip for online monitoring of fungal biofilm dynamics. *Lab. Chip* **2007**, *7*, 1723–1731.

394. Peters, A.C.; Wimpenny, J.W. A constant-depth laboratory model film fermentor. *Biotechnol. Bioeng.* **1988**, *32*, 263–270.

395. Wilson, M. Use of constant depth film fermentor in studies of biofilms of oral bacteria. *Methods Enzymol.* **1999**, *310*, 264–279.

396. Pitts, B.; Willse, A.; McFeters, G.A.; Hamilton, M.A.; Zelver, N.; Stewart, P.S. A repeatable laboratory method for testing the efficacy of biocides against toilet bowl biofilms. *J. Appl. Microbiol.* **2001**, *91*, 110–117.

397. Benoit, M.R.; Conant, C.G.; Ionescu-Zanetti, C.; Schwartz, M.; Matin, A. New device for high-throughput viability screening of flow biofilms. *Appl. Environ. Microbiol.* **2010**, *76*, 4136–4142.

398. Lawrence, J.R.; Swerhone, G.D.; Neu, T.R. A simple rotating annular reactor for replicated biofilm studies. *J. Microbiol. Methods* **2000**, *42*, 215–224.
399. Hodgson, A.E.; Nelson, S.M.; Brown, M.R.; Gilbert, P. A simple *in vitro* model for growth control of bacterial biofilms. *J. Appl. Bacteriol.* **1995**, *79*, 87–93.

400. Gilbert, P.; Allison, D.G.; Evans, D.J.; Handley, P.S.; Brown, M.R. Growth rate control of adherent bacterial populations. *Appl. Environ. Microbiol.* **1989**, *55*, 1308–1311.

401. Schaller, M.; Schafer, W.; Korting, H.C.; Hube, B. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. *Mol. Microbiol.* **1998**, *29*, 605–615.

402. Guggenheim, B.; Giertsen, E.; Schüpbach, P.; Shapiro, S. Validation of an *in vitro* biofilm model of supragingival plaque. *J. Dental Res.* **2001**, *80*, 363–370.

403. Guggenheim, M.; Thurnheer, T.; Gmur, R.; Giovanoli, P.; Guggenheim, B. Validation of the Zurich burn-biofilm model. *Burns J. Int. Soc. Burn Injuries* **2011**, *37*, 1125–1133.

404. Grubb, S.E.; Murdoch, C.; Sudbery, P.E.; Saville, S.P.; Lopez-Ribot, J.L.; Thornhill, M.H. Adhesion of *Candida albicans* to endothelial cells under physiological conditions of flow. *Infect. Immun.* **2009**, *77*, 3872–3878.

405. Woodworth, B.A.; Tamashiro, E.; Bhargave, G.; Cohen, N.A.; Palmer, J.N. An *in vitro* model of *Pseudomonas aeruginosa* biofilms on viable airway epithelial cell monolayers. *Am. J. Rhinol.* **2008**, *22*, 235–238.

406. McBain, A.J.; Sissons, C.; Ledder, R.G.; Sreenivasan, P.K.; De Vizio, W.; Gilbert, P. Development and characterization of a simple perfused oral microcosm. *J. Appl. Microbiol.* **2005**, *98*, 624–634.

407. Kim, J.; Hegde, M.; Jayaraman, A. Microfluidic co-culture of epithelial cells and bacteria for investigating soluble signal-mediated interactions. *J. Vis. Exp.* **2010**, *38*, e1749.

408. Huang, T.Y.; Gulabivala, K.; Ng, Y.L. A bio-molecular film *ex vivo* model to evaluate the influence of canal dimensions and irrigation variables on the efficacy of irrigation. *Int. Endodontic J.* **2008**, *41*, 60–71.

409. Chuang-Smith, O.N.; Wells, C.L.; Henry-Stanley, M.J.; Dunny, G.M. Acceleration of *Enterococcus faecalis* biofilm formation by aggregation substance expression in an *ex vivo* model of cardiac valve colonization. *PLoS One* **2010**, *5*, e15798.

410. Carterson, A.J.; Honer zu Bentrup, K.; Ott, C.M.; Clarke, M.S.; Pierson, D.L.; Vanderburg, C.R.; Buchanan, K.L.; Nickerson, C.A.; Schurr, M.J. A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for *Pseudomonas aeruginosa* pathogenesis. *Infect. Immun.* **2005**, *73*, 1129–1140.

411. Nickerson, C.A.; Goodwin, T.J.; Terlonge, J.; Ott, C.M.; Buchanan, K.L.; Uicker, W.C.; Emami, K.; LeBlanc, C.L.; Ramamurthy, R.; Clarke, M.S.; et al. Three-dimensional tissue assemblies: novel models for the study of *Salmonella enterica* serovar Typhimurium pathogenesis. *Infect. Immun.* **2001**, *69*, 7106–7120.

412. Smith, Y.C.; Grande, K.K.; Rasmussen, S.B.; O'Brien, A.D. Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic *Escherichia coli* with terminally differentiated human urothelial cells. *Infect. Immun.* **2006**, *74*, 750–757.

413. Benghezal, M.; Adam, E.; Lucas, A.; Burn, C.; Orchard, M.G.; Deuschel, C.; Valentino, E.; Braillard, S.; Paccaud, J.P.; Cosson, P. Inhibitors of bacterial virulence identified in a surrogate host model. *Cell Microbiol.* **2007**, *9*, 1336–1342.
414. Sandstrom, G.; Saeed, A.; Abd, H. Acanthamoeba-bacteria: a model to study host interaction with human pathogens. *Curr. Drug Targets* **2011**, *12*, 936–941.

415. Annesley, S.J.; Fisher, P.R. *Dictyostelium discoideum*--a model for many reasons. *Mol. Cell. Biochem.* **2009**, *329*, 73–91.

416. Silo-Suh, L.; Suh, S.J.; Sokol, P.A.; Ohman, D.E. A simple alfalfa seedling infection model for *Pseudomonas aeruginosa* strains associated with cystic fibrosis shows AlgT (sigma-22) and RhlR contribute to pathogenesis. *Proc. Natl. Acad. Sci. USA* **2002**, *99*, 15699–15704.

417. Schlaich, N.L. *Arabidopsis thaliana*-- the model plant to study host-pathogen interactions. *Curr. Drug Targets* **2011**, *12*, 955–966.

418. Graf, J. Symbiosis of *Aeromonas veronii* biovar sobria and *Hirudo medicinalis*, the medicinal leech: a novel model for digestive tract associations. *Infect. Immun.* **1999**, *67*, 1–7.

419. Laws, T.R.; Smith, S.A.; Smith, M.P.; Harding, S.V.; Atkins, T.P.; Titball, R.W. The nematode *Panagrellus redivivus* is susceptible to killing by human pathogens at 37 degrees C. *FEMS Microbiol. Lett.* **2005**, *250*, 77–83.

420. Marsh, E.K.; May, R.C. *Caenorhabditis elegans*, a model organism for investigating immunity. *Appl. Environ. Microbiol.* **2012**, *78*, 2075–2081.

421. Jander, G.; Rahme, L.G.; Ausubel, F.M. Positive correlation between virulence of *Pseudomonas aeruginosa* mutants in mice and insects. *J. Bacteriol.* **2000**, *182*, 3843–3845.

422. Kounatidis, I.; Ligoxygakis, P. *Drosophila* as a model system to unravel the layers of innate immunity to infection. *Open Biol.* **2012**, *2*, 120075.

423. Kanther, M.; Rawls, J.F. Host-microbe interactions in the developing zebrafish. *Curr. Opin. Immunol.* **2010**, *22*, 10–19.

424. Yanagihara, K.; Ohnishi, Y.; Morinaga, Y.; Nakamura, S.; Kurihara, S.; Seki, M.; Izumikawa, K.; Kakeya, H.; Yamamoto, Y.; Yamada, Y.; et al. Efficacy of ME1036 against meticillin-resistant *Staphylococcus aureus* and vancomycin-insensitive *S. aureus* in a model of haematogenous pulmonary infection. *Int. J. Antimicrob. Agents* **2008**, *32*, 401–404.

425. Yanagihara, K.; Seki, M.; Izumikawa, K.; Higashiyama, Y.; Miyazaki, Y.; Hirakata, Y.; Tomono, K.; Mizuta, Y.; Tsukamoto, K.; Kohno, S. Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate *Staphylococcus aureus*. *Int. J. Antimicrob. Agents* **2006**, *28*, 212–216.

426. Rogers, C.S.; Hao, Y.; Rokhlina, T.; Samuel, M.; Stoltz, D.A.; Li, Y.; Petroff, E.; Vermeer, D.W.; Kabel, A.C.; Yan, Z.; et al. Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. *J. Clin. Invest.* **2008**, *118*, 1571–1577.

427. Clerc, M.; Bebear, C.; Goursolle, M.; Aparicio, M. Calculi experimentally obtained in the rat by intrarenal injection of *Ureaplasma urealyticum*. *Ann. Biol. Clin. (Paris)* **1984**, *42*, 277–281.

428. Gurjala, A.N.; Geringer, M.R.; Seth, A.K.; Hong, S.J.; Smeltzer, M.S.; Galiano, R.D.; Leung, K.P.; Mustoe, T.A. Development of a novel, highly quantitative *in vivo* model for the study of biofilm-impaired cutaneous wound healing. *Wound Repair. Regen* **2011**, *19*, 400–410.

429. Swords, W.E.; Moore, M.L.; Godzicki, L.; Bukofzer, G.; Mitten, M.J.; VonCannon, J. Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable *Haemophilus influenzae*. *Infect. Immun.* **2004**, *72*, 106–113.
430. Hasturk, H.; Kantarci, A.; Goguet-Surmenian, E.; Blackwood, A.; Andry, C.; Serhan, C.N.; Van Dyke, T.E. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis *in vivo*. *J. Immunol.* **2007**, *179*, 7021–7029.

431. Pouliot, M.; Clish, C.B.; Petasis, N.A.; Van Dyke, T.E.; Serhan, C.N. Lipoxin A(4) analogues inhibit leukocyte recruitment to *Porphyromonas gingivalis*: a role for cyclooxygenase-2 and lipoxins in periodontal disease. *Biochemistry* **2000**, *39*, 4761–4768.

432. Andes, D.; Nett, J.; Oschel, P.; Albrecht, R.; Marchillo, K.; Pitula, A. Development and characterization of an *in vivo* central venous catheter *Candida albicans* biofilm model. *Infect. Immun.* **2004**, *72*, 6023–6031.

433. Kurosaka, Y.; Ishida, Y.; Yamamura, E.; Takase, H.; Otani, T.; Kumon, H. A non-surgical rat model of foreign body-associated urinary tract infection with *Pseudomonas aeruginosa*. *Microbiol. Immunol.* **2001**, *45*, 9–15.

434. Mayberry-Carson, K.J.; Tober-Meyer, B.; Lambe, D.W., Jr.; Costerton, J.W. An electron microscopic study of the effect of clindamycin therapy on bacterial adherence and glycocalyx formation in experimental *Staphylococcus aureus* osteomyelitis. *Microbios* **1986**, *48*, 189–206.

435. Eerenberg, J.P.; Patka, P.; Haarman, H.J.; Dwars, B.J. A new model for posttraumatic osteomyelitis in rabbits. *J. Invest. Surg.* **1994**, *7*, 453–465.

436. Del Pozo, J.L.; Rouse, M.S.; Euba, G.; Kang, C.I.; Mandrekar, J.N.; Steckelberg, J.M.; Patel, R. The electricidal effect is active in an experimental model of *Staphylococcus epidermidis* chronic foreign body osteomyelitis. *Antimicrob. Agents Chemother.* **2009**, *53*, 4064–4068.

437. Poelstra, K.A.; Barekzi, N.A.; Grainger, D.W.; Gristina, A.G.; Schuler, T.C. A novel spinal implant infection model in rabbits. *Spine (Phila Pa 1976)* **2000**, *25*, 406–410.

438. Li, D.; Gromov, K.; Soballe, K.; Puzas, J.E.; O'Keefe, R.J.; Awad, H.; Drissi, H.; Schwarz, E.M. Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. *J. Orthop. Res.* **2008**, *26*, 96–105.

439. Philipov, J.P.; Pascalev, M.D.; Aminkov, B.Y.; Grosev, C.D. Changes in serum carboxyterminal telopeptide of type I collagen in an experimental model of canine osteomyelitis. *Calcif Tissue Int.* **1995**, *57*, 152–154.

440. Williams, D.L.; Haymond, B.S.; Woodbury, K.L.; Beck, J.P.; Moore, D.E.; Epperson, R.T.; Bloebaum, R.D. Experimental model of biofilm implant-related osteomyelitis to test combination biomaterials using biofilms as initial inocula. *J. Biomed. Mater. Res. A* **2012**, *100*, 1888–1900.

441. Southwood, R.T.; Rice, J.L.; McDonald, P.J.; Hakendorf, P.H.; Rozenbilds, M.A. Infection in experimental hip arthroplasties. *J. Bone Joint Surg. Br.* **1985**, *67*, 229–231.

442. Bergamini, T.M.; Bandyk, D.F.; Govostis, D.; Kaebnick, H.W.; Towne, J.B. Infection of vascular prostheses caused by bacterial biofilms. *J. Vasc. Surg.* **1988**, *7*, 21–30.

443. Farooq, M.; Freischlag, J.; Kelly, H.; Seabrook, G.; Cambria, R.; Towne, J. Gelatin-sealed polyester resists *Staphylococcus epidermidis* biofilm infection. *J. Surg. Res.* **1999**, *87*, 57–61.

444. Arad, E.; Navon-Venezia, S.; Gur, E.; Kuzmenko, B.; Glick, R.; Frenkiel-Krispin, D.; Kramer, E.; Carmeli, Y.; Barnea, Y. Novel Rat Model of Methicillin-Resistant *Staphylococcus aureus* Infected Silicone Breast-Implants: A Study of Biofilm Pathogenesis. *Plast Reconstr. Surg.* **2013**, *131*, 205-214.
445. Chilukuri, D.M.; Shah, J.C. Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections. *Pharm Res.* **2005**, *22*, 563–572.

446. Hessburg, P.C.; Truant, J.P.; Penn, W.P. Treatment of *Pseudomonas* keratitis in rabbits. *Am. J. Ophthalmol.* **1966**, *61*, 49–54.

447. Fulcher, T.P.; Dart, J.K.; McLaughlin-Borlace, L.; Howes, R.; Matheson, M.; Cree, I. Demonstration of biofilm in infectious crystalline keratopathy using ruthenium red and electron microscopy. *Ophthalmology* **2001**, *108*, 1088–1092.

448. Engelbert, M.; Gilmore, M.S. Fas ligand but not complement is critical for control of experimental *Staphylococcus aureus* Endophthalmitis. *Invest. Ophthalmol. Vis. Sci.* **2005**, *46*, 2479–2486.

449. Elder, M.J.; Stapleton, F.; Evans, E.; Dart, J.K. Biofilm-related infections in ophthalmology. *Eye* (Lond) **1995**, *9*, 102–109.

450. Shea, P.R.; Virtaneva, K.; Kupko, J.J., 3rd; Porcella, S.F.; Barry, W.T.; Wright, F.A.; Kobayashi, S.D.; Carmody, A.; Ireland, R.M.; Sturdevant, D.E.; et al. Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A *Streptococcus. Proc. Natl. Acad. Sci. USA* **2010**, *107*, 4693–4698.

451. Chole, R.A.; Faddis, B.T. Anatomical evidence of microbial biofilms in tonsillar tissues: a possible mechanism to explain chronicity. *Arch. Otolaryngol. Head Neck Surg.* **2003**, *129*, 634–636.

452. Post, J.C.; Hiller, N.L.; Nistico, L.; Stoodley, P.; Ehrlich, G.D. The role of biofilms in otolaryngologic infections: update 2007. *Curr. Opin. Otolaryngol. Head Neck Surg.* **2007**, *15*, 347–351.

453. McDuffie, R.S., Jr.; Kunze, M.; Barr, J.; Wolf, D.; Sze, C.I.; Shikes, R.; Sherman, M.; Gibbs, R.S. Chronic intrauterine and fetal infection with *Gardnerella vaginalis*. *Am. J. Obstet Gynecol.* **2002**, *187*, 1263–1266.

454. Verstraelen, H.; Swidsinski, A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. *Curr. Opin. Infect. Dis.* **2013**, *26*, 86–89.

455. Klein, M.; Obermaier, B.; Angele, B.; Pfister, H.W.; Wagner, H.; Koedel, U.; Kirschning, C.J. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. *J. Infect. Dis.* **2008**, *198*, 1028–1036.

456. Neil, R.B.; Apicella, M.A. Clinical and laboratory evidence for *Neisseria meningitidis* biofilms. *Future Microbiol.* **2009**, *4*, 555–563.

457. Ruellan, K.; Frijns, J.H.; Bloemberg, G.V.; Hautefort, C.; Van den Abbeele, T.; Lamers, G.E.; Herman, P.; Huy, P.T.; Kania, R.E. Detection of bacterial biofilm on cochlear implants removed because of device failure, without evidence of infection. *Otol. Neurotol.* **2010**, *31*, 1320–1324.

458. Everaert, E.P.; van de Belt-Gritter, B.; van der Mei, H.C.; Busscher, H.J.; Verkerke, G.J.; Dijk, F.; Mahieu, H.F.; Reitsma, A. *In vitro* and *in vivo* microbial adhesion and growth on argon plasma-treated silicone rubber voice prostheses. *J. Mater Sci. Mater Med.* **1998**, *9*, 147–157.

459. Braxton, E.E., Jr.; Ehrlich, G.D.; Hall-Stoodley, L.; Stoodley, P.; Veeh, R.; Fux, C.; Hu, F.Z.; Quigley, M.; Post, J.C. Role of biofilms in neurosurgical device-related infections. *Neurosurg. Rev.* **2005**, *28*, 249–255.
460. Wilson, S.K.; Costerton, J.W. Biofilm and penile prosthesis infections in the era of coated implants: a review. *J. Sex. Med.* **2012**, *9*, 44–53.

461. Ginsberg, G.; Cope, C.; Shah, J.; Martin, T.; Carty, A.; Habecker, P.; Kaufmann, C.; Clerc, C.; Nuutinen, J.P.; Tormala, P. *In vivo* evaluation of a new bioabsorbable self-expanding biliary stent. *Gastrointest Endosc.* **2003**, *58*, 777–784.

462. Guaglianone, E.; Cardines, R.; Vuotto, C.; Di Rosa, R.; Babini, V.; Mastrantonio, P.; Donelli, G. Microbial biofilms associated with biliary stent clogging. *FEMS Immunol. Med. Microbiol. 2010*, *59*, 410–420.

© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).